TrialDiabetes, obesity & metabolism2013

Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial.

K Kaku et al.PubMed ↗Publisher ↗

No numbers read from the abstract.